Please login to the form below

Not currently logged in
Email:
Password:

Novo Nordisk's diabetes programme in India

Denmark-based Novo Nordisk is to offer free insulin and diabetes care to children in India as part of the pharmaceutical firm's Changing Diabetes in Children programme

Denmark-based Novo Nordisk is to offer free insulin and diabetes care to children in India as part of the pharmaceutical firm's Changing Diabetes in Children programme.

The programme is a partnership initiative that works to improve the provision of childhood diabetes care in developing countries.

Novo will set up 12 clinics covering a total of 10 Indian states. The company said it aims to reach 2,500 children with diabetes in a country where more than 50 million people are living with the condition.

Children will receive insulin, blood glucometers and blood strips, while healthcare professionals and diabetes educators will receive a comprehensive training manual and locally adapted educational materials for children and their families.

It is hope that, by the end of 2015, a sustainable cooperation with local partners, including governments and diabetes associations, should be in place to continue with the clinic's work.

The programme is already active in seven other countries including Bangladesh, Cameroon and Uganda, with Novo's intention to provide care to 10,000 children by 2015.

8th September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics